ITGB3 (Integrin beta-3) variants and mutations
ITGB3 (also known as Integrin beta-3) is a human protein-coding gene encoding an integrin beta-3 protein. In platelets it pairs with ITGA2B to bind fibrinogen and mediate aggregation, while in other cells it forms integrins involved in matrix adhesion and signaling. Biallelic loss-of-function variants cause Glanzmann thrombasthenia. This analysis covers 1,138 ITGB3 variants and mutations. Of these, 77% have computational variant effect predictions. Disease context includes Glanzmann thrombasthenia 1, Glanzmann thrombasthenia, and bleeding disorder, platelet-type, 24. Example ITGB3 variants include M1L, M1T, and R2P.
Variant analysis overview
- Gene: ITGB3
- Protein: Integrin beta-3
- UniProt accession: P05106
- Organism: Homo sapiens
- Variants analyzed: 1138
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 936 unspecified-consequence records; 63 synonymous variants; 3 stop-gained variants; 113 missense variants; 3 in-frame deletions; 17 frameshift variants; 3 splice-region variants
- Prediction scores: 879 variants have prediction scores (77% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Glanzmann thrombasthenia 1, Glanzmann thrombasthenia, bleeding disorder, platelet-type, 24, autosomal dominant macrothrombocytopenia, cancer, myocardial infarction, acute coronary syndrome, Noonan syndrome, hypertrophic cardiomyopathy, Costello syndrome, Recurrent thrombophlebitis, intermediate coronary syndrome.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 6 domains; 14 binding sites; 10 post-translational modification sites.
- Structural context: 592 variants have structural context.
- PTM context: 8 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable ITGB3 variants
Examples include M1L, M1T, R2P, R2Q, R2R, R2*, R2L, A3E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1L (p.Met1Leu), rs2064976742, ClinGen CA400028177, ClinVar RCV003864212, MetaLR 0.14, MetaSVM -0.89, Uncertain significance, not provided
- M1T (p.Met1Thr), rs1239823207, ClinGen CA400028186, ClinVar RCV003222578, MetaLR 0.12, MetaSVM -0.92, Uncertain significance, Glanzmann thrombasthenia
- R2P (p.Arg2Pro), TOPMed rs1343433641, gnomAD rs1343433641
- R2Q (p.Arg2Gln), TOPMed rs1343433641, gnomAD rs1343433641, MetaLR 0.09, MetaSVM -1.03
- R2R (p.Arg2Arg), gnomAD 17-47253865-C-A, CADD 14.00
- R2* (p.Arg2Ter), gnomAD 17-47253865-C-T, CADD 43.00
- R2L (p.Arg2Leu), gnomAD 17-47253866-G-T, MetaLR 0.08, MetaSVM -1.05
- A3E (p.Ala3Glu), TOPMed rs1286557894, gnomAD rs1286557894, MetaLR 0.09, MetaSVM -0.96
- A3P (p.Ala3Pro), rs1337664600, ClinGen CA400028213, ClinVar RCV003873214, TOPMed rs1337664600, MetaLR 0.08, MetaSVM -0.84, Uncertain significance, not provided
- A3V (p.Ala3Val), TOPMed rs1286557894, gnomAD rs1286557894, MetaLR 0.09, MetaSVM -0.96
- A3S (p.Ala3Ser), gnomAD 17-47253868-G-T, MetaLR 0.08, MetaSVM -0.85
- A3T (p.Ala3Thr), gnomAD 17-47253868-G-A, MetaLR 0.05, MetaSVM -1.02
- A3A (p.Ala3Ala), gnomAD 17-47253870-G-A, CADD 13.80
- R4R (p.Arg4Arg), gnomAD 17-47253871-C-A, CADD 12.90
- R4W (p.Arg4Trp), gnomAD 17-47253871-C-T, MetaLR 0.05, MetaSVM -0.92
- R4L (p.Arg4Leu), gnomAD 17-47253872-G-T, MetaLR 0.04, MetaSVM -1.05
- R4Q (p.Arg4Gln), gnomAD 17-47253872-G-A, MetaLR 0.04, MetaSVM -1.07
- R4P (p.Arg4Pro), gnomAD 17-47253872-G-C, MetaLR 0.04, MetaSVM -1.07
- P5L (p.Pro5Leu), TOPMed rs897126842, gnomAD rs897126842, MetaLR 0.03, MetaSVM -1.10
- P5R (p.Pro5Arg), TOPMed rs897126842, gnomAD rs897126842, MetaLR 0.03, MetaSVM -1.09
- P5A (p.Pro5Ala), gnomAD 17-47253874-C-G, MetaLR 0.04, MetaSVM -1.02
- P5T (p.Pro5Thr), gnomAD 17-47253874-C-A, MetaLR 0.05, MetaSVM -1.05
- P5S (p.Pro5Ser), gnomAD 17-47253874-C-T, MetaLR 0.05, MetaSVM -1.05
- P5Q (p.Pro5Gln), gnomAD 17-47253875-C-A, MetaLR 0.04, MetaSVM -1.09
- P5P (p.Pro5Pro), gnomAD 17-47253876-G-T, CADD 7.53
- R6G (p.Arg6Gly), ExAC rs752525603, TOPMed rs752525603, gnomAD rs752525603, MetaLR 0.04, MetaSVM -1.09, Uncertain significance
- R6L (p.Arg6Leu), rs762907751, ClinGen CA8622828, ClinVar RCV003739768, 1000Genomes rs762907751, MetaLR 0.04, MetaSVM -1.05, Uncertain significance, not provided
- R6P (p.Arg6Pro), 1000Genomes rs762907751, ExAC rs762907751, TOPMed rs762907751, gnomAD rs762907751, MetaLR 0.04, MetaSVM -1.07, Uncertain significance, not provided; Inborn genetic diseases
- R6Q (p.Arg6Gln), rs762907751, ClinGen CA400028247, ClinVar RCV003207851, ClinVar RCV003720792, MetaLR 0.04, MetaSVM -1.05, Uncertain significance, Inborn genetic diseases; not provided
- R6W (p.Arg6Trp), rs752525603, ClinGen CA8622827, ClinVar RCV001127479, ClinVar RCV002556788, MetaLR 0.04, MetaSVM -1.05, Uncertain significance, not provided; Glanzmann thrombasthenia
- R6R (p.Arg6Arg), gnomAD 17-47253877-C-A, CADD 6.34
- P7L (p.Pro7Leu), rs1216806597, ClinGen CA400028261, ClinVar RCV003882179, TOPMed rs1216806597, MetaLR 0.06, MetaSVM -1.00, Uncertain significance, not provided
- P7S (p.Pro7Ser), rs995924582, ClinGen CA291240262, ClinVar RCV001127480, ClinVar RCV005582545, MetaLR 0.04, MetaSVM -1.06, Uncertain significance, Inborn genetic diseases; Glanzmann thrombasthenia
- P7R (p.Pro7Arg), gnomAD 17-47253877-CGGCC, CADD 21.80
- P7T (p.Pro7Thr), gnomAD 17-47253880-C-A, MetaLR 0.04, MetaSVM -1.04
- P7H (p.Pro7His), gnomAD 17-47253881-C-A, MetaLR 0.06, MetaSVM -0.99
- P7P (p.Pro7Pro), rs1027548991, gnomAD 17-47253882-C-T, CADD 8.12
- R8G (p.Arg8Gly), NCI-TCGA TCGA novel, MetaLR 0.05, MetaSVM -1.04, Variant assessed as somatic; high impact.
- R8L (p.Arg8Leu), TOPMed rs910005054, gnomAD rs910005054, MetaLR 0.05, MetaSVM -1.04, Uncertain significance
- R8P (p.Arg8Pro), rs910005054, ClinGen CA400028271, ClinVar RCV003562898, TOPMed rs910005054, MetaLR 0.05, MetaSVM -1.04, Uncertain significance, Inborn genetic diseases; not provided
- R8Q (p.Arg8Gln), rs910005054, ClinGen CA291240277, ClinVar RCV002817938, TOPMed rs910005054, MetaLR 0.05, MetaSVM -1.05, Uncertain significance, Inborn genetic diseases
- R8W (p.Arg8Trp), TOPMed rs952078066, gnomAD rs952078066, MetaLR 0.03, MetaSVM -0.99
- p.Arg8 Pro9del, gnomAD 17-47253876-GCGGC, CADD 11.30
- R8R (p.Arg8Arg), rs952078066, gnomAD 17-47253883-C-A, CADD 8.52
- P9L (p.Pro9Leu), ExAC rs763800456, TOPMed rs763800456, gnomAD rs763800456, MetaLR 0.04, MetaSVM -1.04
- P9R (p.Pro9Arg), ExAC rs763800456, TOPMed rs763800456, gnomAD rs763800456, MetaLR 0.04, MetaSVM -1.01, Uncertain significance, Inborn genetic diseases
- P9S (p.Pro9Ser), gnomAD 17-47253886-C-T, MetaLR 0.06, MetaSVM -1.01
- P9T (p.Pro9Thr), gnomAD 17-47253886-C-A, MetaLR 0.06, MetaSVM -1.03
- P9Q (p.Pro9Gln), gnomAD 17-47253887-C-A, MetaLR 0.04, MetaSVM -1.00
- P9P (p.Pro9Pro), gnomAD 17-47253888-G-C, CADD 10.30
- L10F (p.Leu10Phe), gnomAD rs1489964393, MetaLR 0.05, MetaSVM -1.02, Uncertain significance, not provided
- L10V (p.Leu10Val), gnomAD rs1489964393, MetaLR 0.06, MetaSVM -1.02
- L10R (p.Leu10Arg), gnomAD 17-47253887-CGCTC, CADD 26.10
- L10I (p.Leu10Ile), gnomAD 17-47253889-C-A, MetaLR 0.05, MetaSVM -1.03
- L10P (p.Leu10Pro), gnomAD 17-47253890-T-C, MetaLR 0.07, MetaSVM -1.01
- L10L (p.Leu10Leu), gnomAD 17-47253891-C-A, CADD 10.50
- W11L (p.Trp11Leu), TOPMed rs941154306, MetaLR 0.11, MetaSVM -1.06
- W11R (p.Trp11Arg), rs1022839092, ClinGen CA291240306, ClinVar RCV001225262, ClinVar RCV001360644, MetaLR 0.04, MetaSVM -1.03, Pathogenic, Glanzmann thrombasthenia
- W11G (p.Trp11Gly), gnomAD 17-47253888-GCT-G, CADD 24.50
- W11* (p.Trp11Ter), gnomAD 17-47253893-G-A, CADD 44.00
- W11S (p.Trp11Ser), gnomAD 17-47253893-G-C, MetaLR 0.10, MetaSVM -1.05
- W11C (p.Trp11Cys), gnomAD 17-47253894-G-C, MetaLR 0.07, MetaSVM -0.94
- A12E (p.Ala12Glu), rs1051430, ClinGen CA400028311, ClinVar RCV003175960, MetaLR 0.04, MetaSVM -0.99, Uncertain significance, Inborn genetic diseases
- A12T (p.Ala12Thr), Ensembl rs971134148, MetaLR 0.05, MetaSVM -0.98
- A12V (p.Ala12Val), Ensembl rs1051430, MetaLR 0.04, MetaSVM -0.95
- A12R (p.Ala12Arg), gnomAD 17-47253892-TG-T, CADD 25.80
- A12S (p.Ala12Ser), gnomAD 17-47253895-G-T, MetaLR 0.05, MetaSVM -0.98
- A12G (p.Ala12Gly), gnomAD 17-47253896-C-G, MetaLR 0.06, MetaSVM -0.97
- A12A (p.Ala12Ala), rs751163149, gnomAD 17-47253897-G-T, CADD 8.19
- T13I (p.Thr13Ile), TOPMed rs1327039997, MetaLR 0.06, MetaSVM -1.00
- T13S (p.Thr13Ser), gnomAD 17-47253898-A-T, MetaLR 0.07, MetaSVM -0.98
- T13A (p.Thr13Ala), gnomAD 17-47253898-A-G, MetaLR 0.07, MetaSVM -0.97
- T13N (p.Thr13Asn), gnomAD 17-47253899-C-A, MetaLR 0.06, MetaSVM -1.01
- T13T (p.Thr13Thr), gnomAD 17-47253900-T-G, CADD 8.48
- V14M (p.Val14Met), rs115600591, ClinGen CA8622831, ClinVar RCV000224944, ClinVar RCV000364007, MetaLR 0.01, MetaSVM -1.05, Benign, Glanzmann thrombasthenia
- V14L (p.Val14Leu), gnomAD 17-47253901-G-C, MetaLR 0.06, MetaSVM -0.98
- V14E (p.Val14Glu), gnomAD 17-47253902-T-A, MetaLR 0.08, MetaSVM -1.03
- V14A (p.Val14Ala), gnomAD 17-47253902-T-C, MetaLR 0.08, MetaSVM -1.02
- V14V (p.Val14Val), gnomAD 17-47253903-G-C, CADD 13.20
- L15M (p.Leu15Met), gnomAD 17-47253904-C-A, MetaLR 0.08, MetaSVM -1.04
- L15L (p.Leu15Leu), rs924366145, gnomAD 17-47253904-C-T, CADD 14.80
- L15V (p.Leu15Val), gnomAD 17-47253904-C-G, MetaLR 0.08, MetaSVM -1.05
- L15P (p.Leu15Pro), gnomAD 17-47253905-T-C, MetaLR 0.08, MetaSVM -1.06
- A16E (p.Ala16Glu), TOPMed rs2064977275, gnomAD rs2064977275, MetaLR 0.07, MetaSVM -0.88
- A16S (p.Ala16Ser), gnomAD rs1157059502, MetaLR 0.08, MetaSVM -0.95
- A16T (p.Ala16Thr), gnomAD 17-47253907-G-A, MetaLR 0.08, MetaSVM -0.99
- A16P (p.Ala16Pro), gnomAD 17-47253907-G-C, MetaLR 0.09, MetaSVM -1.06
- A16V (p.Ala16Val), gnomAD 17-47253908-C-T, MetaLR 0.08, MetaSVM -0.97
- A16G (p.Ala16Gly), gnomAD 17-47253908-C-G, MetaLR 0.08, MetaSVM -0.98
- A16A (p.Ala16Ala), rs934316834, gnomAD 17-47253909-G-A, CADD 15.70
- L17M (p.Leu17Met), gnomAD 17-47253910-C-A, MetaLR 0.10, MetaSVM -1.05
- L17V (p.Leu17Val), gnomAD 17-47253910-C-G, MetaLR 0.09, MetaSVM -1.07
- L17L (p.Leu17Leu), rs780711301, gnomAD 17-47253910-C-T, CADD 14.90
- L17R (p.Leu17Arg), gnomAD 17-47253911-T-G, MetaLR 0.10, MetaSVM -1.02
- L17P (p.Leu17Pro), gnomAD 17-47253911-T-C, MetaLR 0.12, MetaSVM -0.99
- G18E (p.Gly18Glu), TOPMed rs1444188478, gnomAD rs1444188478, MetaLR 0.08, MetaSVM -1.08
- G18R (p.Gly18Arg), ExAC rs749973154, TOPMed rs749973154, gnomAD rs749973154, MetaLR 0.11, MetaSVM -1.03, Uncertain significance, not provided
- p.Gly18 Leu20del, gnomAD 17-47253905-TGGCG, CADD 22.40
- G18W (p.Gly18Trp), gnomAD 17-47253913-G-T, MetaLR 0.16, MetaSVM -0.93
- G18A (p.Gly18Ala), gnomAD 17-47253914-G-C, MetaLR 0.05, MetaSVM -1.07
- G18V (p.Gly18Val), gnomAD 17-47253914-G-T, MetaLR 0.07, MetaSVM -1.04
- G18G (p.Gly18Gly), gnomAD 17-47253915-G-T, CADD 14.60
- A19T (p.Ala19Thr), 1000Genomes rs2149057080, MetaLR 0.06, MetaSVM -1.09
- A19G (p.Ala19Gly), rs1302506624, gnomAD 17-47253911-T-TG, CADD 34.00
- A19R (p.Ala19Arg), rs1302506624, gnomAD 17-47253911-TG-T, CADD 32.00
- A19S (p.Ala19Ser), gnomAD 17-47253916-G-T, MetaLR 0.07, MetaSVM -1.08
- A19P (p.Ala19Pro), gnomAD 17-47253916-G-C, MetaLR 0.09, MetaSVM -1.04
- A19V (p.Ala19Val), gnomAD 17-47253917-C-T, MetaLR 0.03, MetaSVM -0.93
- A19E (p.Ala19Glu), gnomAD 17-47253917-C-A, MetaLR 0.10, MetaSVM -1.06
- A19A (p.Ala19Ala), rs534654534, gnomAD 17-47253918-G-T, CADD 15.20
- L20P (p.Leu20Pro), rs2149057083, ClinGen CA400028389, ClinVar RCV002254807, ClinVar RCV005406416, AlphaMissense 0.23, MetaLR 0.06, Uncertain significance, Glanzmann thrombasthenia
- L20R (p.Leu20Arg), rs2149057083, ClinGen CA400028386, ClinVar RCV002281033, ClinVar RCV002511151, AlphaMissense 0.23, MetaLR 0.06, Uncertain significance, Glanzmann thrombasthenia
- L20L (p.Leu20Leu), rs548495900, gnomAD 17-47253919-C-T, CADD 15.30
- L20M (p.Leu20Met), gnomAD 17-47253919-C-A, MetaLR 0.07, MetaSVM -1.06
- L20Q (p.Leu20Gln), gnomAD 17-47253920-T-A, MetaLR 0.06, MetaSVM -1.09
- A21G (p.Ala21Gly), ExAC rs772418775, TOPMed rs772418775, gnomAD rs772418775, MetaLR 0.05, MetaSVM -1.08, Uncertain significance
- A21V (p.Ala21Val), rs772418775, ClinGen CA8622838, cosmic curated COSV71385, ClinVar RCV000523191, MetaLR 0.05, MetaSVM -0.98, Uncertain significance, Glanzmann thrombasthenia
- A21T (p.Ala21Thr), gnomAD 17-47253922-G-A, MetaLR 0.05, MetaSVM -1.12
- A21S (p.Ala21Ser), gnomAD 17-47253922-G-T, MetaLR 0.04, MetaSVM -1.07
- A21E (p.Ala21Glu), gnomAD 17-47253923-C-A, MetaLR 0.06, MetaSVM -1.06
- A21A (p.Ala21Ala), gnomAD 17-47253924-G-T, CADD 14.70
- G22D (p.Gly22Asp), gnomAD rs2064977458, MetaLR 0.07, MetaSVM -1.08
- G22* (p.Gly22Ter), gnomAD 17-47253919-CTGGC, CADD 32.00
- G22A (p.Gly22Ala), gnomAD 17-47253923-CG-C, CADD 32.00
- G22S (p.Gly22Ser), gnomAD 17-47253925-G-A, MetaLR 0.07, MetaSVM -0.98
- G22C (p.Gly22Cys), gnomAD 17-47253925-G-T, MetaLR 0.05, MetaSVM -1.12
- G22V (p.Gly22Val), gnomAD 17-47253926-G-T, MetaLR 0.05, MetaSVM -1.08
- G22G (p.Gly22Gly), gnomAD 17-47253927-C-A, CADD 12.90
- V23F (p.Val23Phe), rs778013385, ClinGen CA8622839, ClinVar RCV004405821, ClinVar RCV004750958, MetaLR 0.06, MetaSVM -0.98, Uncertain significance, Inborn genetic diseases; not provided
- V23I (p.Val23Ile), gnomAD 17-47253928-G-A, MetaLR 0.06, MetaSVM -1.03
- V23L (p.Val23Leu), gnomAD 17-47253928-G-C, MetaLR 0.06, MetaSVM -0.99
- V23A (p.Val23Ala), gnomAD 17-47253929-T-C, MetaLR 0.04, MetaSVM -0.98
- V23V (p.Val23Val), gnomAD 17-47253930-T-C, CADD 11.60
- G24V (p.Gly24Val), TOPMed rs891252528, gnomAD rs891252528, MetaLR 0.07, MetaSVM -1.05, Uncertain significance, Inborn genetic diseases
- G24A (p.Gly24Ala), gnomAD 17-47253930-TG-T, CADD 25.90
- G24C (p.Gly24Cys), gnomAD 17-47253931-G-T, MetaLR 0.04, MetaSVM -1.03
- G24S (p.Gly24Ser), gnomAD 17-47253931-G-A, MetaLR 0.07, MetaSVM -1.03
- G24R (p.Gly24Arg), gnomAD 17-47253931-G-C, MetaLR 0.06, MetaSVM -1.03
- G24D (p.Gly24Asp), gnomAD 17-47253932-G-A, MetaLR 0.07, MetaSVM -1.03
- G24G (p.Gly24Gly), rs768269394, gnomAD 17-47253933-C-T, CADD 12.50
- V25I (p.Val25Ile), gnomAD rs1291704461, MetaLR 0.08, MetaSVM -1.07
- V25L (p.Val25Leu), gnomAD 17-47253934-G-T, MetaLR 0.07, MetaSVM -1.07
- V25A (p.Val25Ala), gnomAD 17-47253935-T-C, MetaLR 0.05, MetaSVM -1.09
- V25E (p.Val25Glu), gnomAD 17-47253935-T-A, MetaLR 0.06, MetaSVM -1.12
- V25V (p.Val25Val), gnomAD 17-47253936-A-T, CADD 7.04
- G26A (p.Gly26Ala), gnomAD rs1207144046, MetaLR 0.06, MetaSVM -0.88, Uncertain significance
- G26E (p.Gly26Glu), gnomAD rs1207144046, MetaLR 0.05, MetaSVM -0.93, Uncertain significance, Inborn genetic diseases
- G26* (p.Gly26Ter), gnomAD 17-47253937-G-T, CADD 42.00
- G26R (p.Gly26Arg), gnomAD 17-47253937-G-A, MetaLR 0.07, MetaSVM -1.00
- G26V (p.Gly26Val), gnomAD 17-47253938-G-T, MetaLR 0.08, MetaSVM -0.99
- G26G (p.Gly26Gly), gnomAD 17-47253939-A-G, CADD 21.60
- G27R (p.Gly27Arg), rs1037047731, ClinGen CA291240434, ClinVar RCV002281034, ClinVar RCV005096021, MetaLR 0.06, MetaSVM -1.02, Conflicting interpretations, Glanzmann thrombasthenia 2; not provided
- G27W (p.Gly27Trp), gnomAD 17-47253940-G-T, MetaLR 0.10, MetaSVM -0.96
- G27G (p.Gly27Gly), rs1401489918, gnomAD 17-47274420-G-A, CADD 8.77
- N29D (p.Asn29Asp), rs967611155, ClinGen CA291259004, ClinVar RCV002864179, ClinVar RCV005021708, MetaLR 0.07, MetaSVM -1.05, Uncertain significance, Inborn genetic diseases; Bleeding disorder, platelet-type, 24; Myocardial infarc
- N29K (p.Asn29Lys), Ensembl rs1567761788, MetaLR 0.08, MetaSVM -1.04
- N29T (p.Asn29Thr), gnomAD 17-47253938-GA-G, CADD 32.00
- N29N (p.Asn29Asn), gnomAD 17-47274426-C-T, CADD 11.20
- I30M (p.Ile30Met), gnomAD 17-47274429-C-G, MetaLR 0.12, MetaSVM -0.89
- C31Y (p.Cys31Tyr), rs2547613534, ClinGen CA400031593, ClinVar RCV002511540, Uncertain significance, Glanzmann thrombasthenia
- T32I (p.Thr32Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T32T (p.Thr32Thr), rs61736877, gnomAD 17-47274435-C-A, CADD 9.77
- T33M (p.Thr33Met), rs544276300, ClinGen CA8622851, cosmic curated COSV71385, ClinVar RCV003724990, MetaLR 0.10, MetaSVM -1.02, Uncertain significance, not specified; not provided
- T33T (p.Thr33Thr), gnomAD 17-47274438-G-T, CADD 3.02
- R34* (p.Arg34Ter), rs75427428, ClinGen CA8622852, NCI-TCGA Cosmic COSV1014, cosmic curated COSV10145, CADD 35.00, Pathogenic
- R34L (p.Arg34Leu), ExAC rs765882558, TOPMed rs765882558, gnomAD rs765882558, MetaLR 0.14, MetaSVM -0.82, Uncertain significance
- R34Q (p.Arg34Gln), rs765882558, ClinGen CA400031621, ClinVar RCV002885669, ExAC rs765882558, MetaLR 0.05, MetaSVM -1.05, Uncertain significance, not provided
- R34R (p.Arg34Arg), rs75427428, gnomAD 17-47274439-C-A, CADD 9.67
- G35S (p.Gly35Ser), TOPMed rs1235786723, gnomAD rs1235786723, MetaLR 0.14, MetaSVM -0.97
- G35D (p.Gly35Asp), gnomAD 17-47274443-G-A, MetaLR 0.17, MetaSVM -0.84
- G35G (p.Gly35Gly), gnomAD 17-47274444-T-C, CADD 2.58
- V36G (p.Val36Gly), gnomAD 17-47274446-T-G, MetaLR 0.13, MetaSVM -0.88
- S37R (p.Ser37Arg), ExAC rs753146344, TOPMed rs753146344, gnomAD rs753146344, MetaLR 0.04, MetaSVM -1.10, Uncertain significance, Inborn genetic diseases; not provided
- p.Ser38 Ser46del, gnomAD 17-47274443-GTGTG, CADD 19.80
- C39G (p.Cys39Gly), rs1880497383, ClinGen CA400031666, ClinVar RCV001225279, TOPMed rs1880497383, AlphaMissense 0.99, MetaLR 0.57, Likely pathogenic, Glanzmann thrombasthenia
- C39R (p.Cys39Arg), TOPMed rs1880497383, AlphaMissense 0.99, MetaLR 0.57, Likely pathogenic
- Q40* (p.Gln40Ter), rs2547613559, ClinGen CA400031679, ClinVar RCV002511542, Pathogenic
- Q40H (p.Gln40His), ExAC rs758852422, gnomAD rs758852422, MetaLR 0.17, MetaSVM -0.87, Uncertain significance, Inborn genetic diseases
- Q40Q (p.Gln40Gln), gnomAD 17-47274459-G-A, CADD 7.96
- Q41* (p.Gln41Ter), rs2547613560, ClinGen CA400031690, ClinVar RCV002511528, CADD 36.00, Pathogenic
Public ITGB3 analysis runs
- ITGB3 analysis run — ITGB3 (1,138 variants) — completed 2026-08-19